detinfДЕТСКИЕ ИНФЕКЦИИCHILDREN INFECTIONS2072-81072618-8139Association of Pediatricians and Infection Disease doctors10.22627/2072-8107-2021-20-3-67-72detinf-612Research ArticleСЛУЧАЙ ИЗ ПРАКТИКИCASE FROM PRACTICALКлинический случай новой коронавирусной инфекции у подростка с язвенным колитомClinical case of a new coronavirus infection in a teenager with ulcerative colitishttps://orcid.org/0000-0002-1960-6868МескинаЕ. Р.MeskinaE. R.

Мескина Елена Руслановна – доктор медицинских наук, заведующая отделением детских инфекций отдела терапии МОНИКИ им. М.Ф. Владимирского.

Москва.

Elena Meskina - MD, Professor.

Moskow.

meskinaelena@rambler.ruhttps://orcid.org/0000-0002-0586-8402ЦелипановаЕ. Е.TselipanovaE. E.

Целипанова Елена Евгеньевна – кандидат медицинских наук, старший научный сотрудник отделения детских инфекций отдела терапии МОНИКИ им. М.Ф. Владимирского.

Москва.

Elena Tselipanova – PhD.

Moskow.

elena-tselip@yandex.ruСохатюкТ. А.SokhatyukT. A.

Сохатюк Татьяна Анатольевна - заведующая детским инфекционным отделением.

Королёв.

Tat'yana Sokhatyuk.

Moscow region, Korolev.

taja-1966@yandex.ruМосковский областной научно-исследовательский клинический институт им. М.Ф. ВладимирскогоРоссияMoscow Regional Research and Clinical Institute (MONIKI)Russian FederationКоролевская городская больницаРоссияKorolev city hospitalRussian Federation2021051020212036772Copyright © Мескина Е.Р., Целипанова Е.Е., Сохатюк Т.А., 20212021Мескина Е.Р., Целипанова Е.Е., Сохатюк Т.А.Meskina E.R., Tselipanova E.E., Sokhatyuk T.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://detinf.elpub.ru/jour/article/view/612

Актуальность наблюдения течения коронавирусной инфекции COVID-19 в сочетании с коморбидной патологией очевидна, так как это новая инфекция c иммунопатологическим патогенезом до конца не изучена.

Представлен клинический случай заболевания COVID-19 у подростка 14 лет из Московской области, развившегося на фоне течения язвенного илеоколита тяжелой формы средней степени активности. Новая коронавирусная инфекция способствовала рецидиву язвенного колита, который потребовал наблюдения и лечения в условиях стационара.

При проведении обследования выявлены: гипохромная постгеморрагическая анемия легкой степени, признаки гиперкоагуляции, характерные для течения язвенного колита; исключены: оппортунистические инфекции, пневмония, острые кишечные инфекции и кишечное кровотечение.

Проведенная стандартная комплексная терапия язвенного колита без включения иммуноссупрессоров позволила избежать более тяжелого и осложненного течения новой коронавирусной инфекции. COVID-19-инфекция у подростка протекала в легкой форме, противовирусная терапия не применялась.

The relevance of monitoring the course of coronavirus infection COVID-19 in combination with comorbid pathology is obvious, since this new infection with immunopathological pathogenesis is not fully understood.

The article presents a clinical case of COVID-19 disease in a 14-year-old teenager from the Moscow region, who developed against the background of severe ulcerative ileocolitis of moderate activity. The new coronavirus infection contributed to the recurrence of ulcerative colitis, which required observation and treatment in a hospital setting.

The examination revealed: mild hypochromic posthemorrhagic anemia, signs of hypercoagulation characteristic of the course of ulcerative colitis; excluded: opportunistic infections, pneumonia, acute intestinal infections and intestinal bleeding.

The standard complex therapy of ulcerative colitis without the inclusion of immunosuppressors made it possible to avoid a more severe and complicated course of the new coronavirus infection. COVID-19 in the teenager was mild, antiviral therapy was not used.

детиCOVID-19язвенный колиттерапияchildrenCOVID-19ulcerative colitistherapyReferencesФедеральная служба по надзору в сфере защиты прав потребителей и благополучия человека. Новости о коронавирусе. [Интернет]. Доступно на: http://www.rospotrebnadzor.ru/about/info/news/Federal'naya sluzhba po nadzoru v sfere zashchity prav potrebitelej i blagopoluchiya cheloveka. Novosti o koronaviruse. [Internet]. http://www.rospotrebnadzor.ru/about/info/news/ (In Russ.)Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; pii: S0140-6736(20)30566-3. doi: 10.1016/S0140-6736(20)30566-3.Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; pii: S0140-6736(20)30566-3. doi: 10.1016/S0140-6736(20)30566-3.Lee P.I., Hu Y.L., Chen P.Y., Huang Y.C., Hsueh P.R. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020; Feb 25. DOI: 10.1016/j.jmii.2020.02.011.Lee P.I., Hu Y.L., Chen P.Y., Huang Y.C., Hsueh P.R. Are children less susceptible to COVID-19? J Microbiol Immunol Infect. 2020; Feb 25. DOI: 10.1016/j.jmii.2020.02.011.Hagmann S. COVID-19 in children: More than meets the eye. Travel Medicine and Infectious Disease. 2020 March 28. DOI: 10.1016/j.tmaid.2020.101649.Hagmann S. COVID-19 in children: More than meets the eye. Travel Medicine and Infectious Disease. 2020 March 28. DOI: 10.1016/j.tmaid.2020.101649.Ludvigsson J.F. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Acta Paediatr. 2020 Mar 23. DOI: 10.1111/apa.15270.Ludvigsson J.F. Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Acta Paediatr. 2020 Mar 23. DOI: 10.1111/apa.15270.Мескина Е.Р. Предварительный клинико-эпидемиологический анализ первых 1000 случаев COVID-19 у детей Московской области. Журнал микробиологии, эпидемиологии и иммунологии. 2020; 97(3). https://doi.org/10.36233/0372-9311-2020-97-3-2.Meskina E.R. Predvaritel'nyj kliniko-epidemiologicheskij analiz pervyh 1000 sluchaev COVID-19 u detej Moskovskoj oblasti. Zhurnal Mikrobiologii, Epidemiologii i Immunologii. 2020; 97(3). (In Russ.) https://doi.org/10.36233/0372-9311-2020-97-3-2Zhang Y.P. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol. 2020; 41:145—151.Zhang Y.P. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Chin J Epidemiol. 2020; 41:145—151.Cao Q., Chen Y.C., Chen C.L., Chiu C.H. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J Formos Med Assoc. 2020 Mar 2; 119(3):670—673. DOI: 10.1016/j.jfma.2020.02.009.Cao Q., Chen Y.C., Chen C.L., Chiu C.H. SARS-CoV-2 infection in children: Transmission dynamics and clinical characteristics. J Formos Med Assoc. 2020 Mar 2; 119(3):670—673. DOI: 10.1016/j.jfma.2020.02.009.Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), 16—24 February 2020: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19), 16—24 February 2020: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.Wu Z., Mc Googan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 February 24 (Epub ahead of print).Wu Z., Mc Googan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 February 24 (Epub ahead of print).Scott D. The Covid-19 risks for different age groups, explained. Vox. 23.03.2020 https://www.vox.com/2020/3/23/21190033/coronavi-rus-covid-19-deaths-by-age.Scott D. The Covid-19 risks for different age groups, explained. Vox. 23.03.2020 https://www.vox.com/2020/3/23/21190033/coronavi-rus-covid-19-deaths-by-age.Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020; doi: 10.1542/peds.2020—0702Dong Y., Mo X., Hu Y., Qi X., Jiang F., Jiang Z., et al. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. Pediatrics. 2020; doi: 10.1542/peds.2020—0702Zimmermann Р., Curtis N. Coronavirus Infections in Children Including COVID-19. Pediatr Infect Dis J. 2020; XX:00—00.Zimmermann Р., Curtis N. Coronavirus Infections in Children Including COVID-19. Pediatr Infect Dis J. 2020; XX:00—00.4. Shekerdemian L.S., Mahmood N.R., Wolfe K.K., Riggs В., Ross С., McKiernan С., et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020 [cited 2020 May 23].1 4. Shekerdemian L.S., Mahmood N.R., Wolfe K.K., Riggs В., Ross С., McKiernan С., et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr. 2020 [cited 2020 May 23].Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J., et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033—4. doi:10.1016/S0140-6736(20)30628-0.Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J., et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020; 395(10229):1033—4. doi:10.1016/S0140-6736(20)30628-0.WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne J.A.C., Murthy S., Diaz J.V., Slutsky A.S., Villar J., Angus D.C., et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020 Sep 2. doi: 10.1001/jama.2020.17023.WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, Sterne J.A.C., Murthy S., Diaz J.V., Slutsky A.S., Villar J., Angus D.C., et al. Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020 Sep 2. doi: 10.1001/jama.2020.17023.Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., et al. SARS-CoV-2 Infection in Children. N Engl J Med [Internet]. 2020 Mar 18; Available from: https://doi.org/10.1056/NEJMc2005073Lu X., Zhang L., Du H., Zhang J., Li Y.Y., Qu J., et al. SARS-CoV-2 Infection in Children. N Engl J Med [Internet]. 2020 Mar 18; Available from: https://doi.org/10.1056/NEJMc2005073Баранов А.А. Федеральные клинические рекомендации по оказанию медицинской помощи детям с язвенным колитом. МЗ РФ. Союз педиатров России. 2016:53. Доступно на: https://docviewer.yandex.ru/view/49118447/.Baranov A.A. Federal'nye klinicheskie rekomendacii po oka-zaniyu medicinskoj pomoshchi detyam s yazvennym kolitom. MZ RF. Soyuz pediatrov Rossii. 2016:53. [Internet]. https://docviewer.yandex.ru/view/49118447/ (In Russ.)Zha A., Wang Y., Zha R. Meta analysis of the changes of blood coagulation in patients with active ulcerative colitis. Xi Bao, Yu Fen, Zi Mian, Yi Xue, Za Zhi. Meta analysis. 2015 Nov; 31(11):1528—32. Chinese.Zha A., Wang Y., Zha R. Meta analysis of the changes of blood coagulation in patients with active ulcerative colitis. Xi Bao, Yu Fen, Zi Mian, Yi Xue, Za Zhi. Meta analysis. 2015 Nov; 31(11):1528—32. Chinese.Benchimol E.I., Fortinsky K.J., Gozdyra P., Van den Heuvel M., Van Limbergen J., MGriffiths A. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm. Bowel. Dis. 2011; 17: 423—439.Benchimol E.I., Fortinsky K.J., Gozdyra P., Van den Heuvel M., Van Limbergen J., MGriffiths A. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm. Bowel. Dis. 2011; 17: 423—439.Henderson P., Hansen R., Cameron F.L., Gerasimidis K., Rogers P., Bisset W.M., et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm. Bowel. Dis. 2012; 18: 999—1005.Henderson P., Hansen R., Cameron F.L., Gerasimidis K., Rogers P., Bisset W.M., et al. Rising incidence of pediatric inflammatory bowel disease in Scotland. Inflamm. Bowel. Dis. 2012; 18: 999—1005.Van Limbergen J., Russell R.K., Drummond H.E., Aldhous M.C., Round N.K., Nimmoet E.R., et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135: 1114—1122.Van Limbergen J., Russell R.K., Drummond H.E., Aldhous M.C., Round N.K., Nimmoet E.R., et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology. 2008; 135: 1114—1122.Turner D., Travis S.P., Griffiths A.M., Ruemmele F.M., Levine A., Benchimol E.I., et al. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBDWorking Group of ESPGHAN. Am J Gastroenterol, 2011;106:574—88.Turner D., Travis S.P., Griffiths A.M., Ruemmele F.M., Levine A., Benchimol E.I., et al. Consensus for managing acute severe ulcerative colitis in children: a systematic review and joint statement from ECCO, ESPGHAN, and the Porto IBDWorking Group of ESPGHAN. Am J Gastroenterol, 2011;106:574—88.Zhang Y.Z., Li Y.Y. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014 Jan 7; 20(1):91—9. doi: 10.3748/wjg.v20.i1.91.Zhang Y.Z., Li Y.Y. Inflammatory bowel disease: pathogenesis. World J Gastroenterol. 2014 Jan 7; 20(1):91—9. doi: 10.3748/wjg.v20.i1.91.Moon J.S. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr Gastroenterol Hepatol Nutr. 2019; 22(1):50—6. doi: 10.5223/pghn.2019.22.1.50.Moon J.S. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr Gastroenterol Hepatol Nutr. 2019; 22(1):50—6. doi: 10.5223/pghn.2019.22.1.50.SECURE (Surveillance Epidemiology of Coronavirus COVID-19 Under Research Exclusion)-IBD DATABASE. Available from. http://www.covidibd.org.SECURE (Surveillance Epidemiology of Coronavirus COVID-19 Under Research Exclusion)-IBD DATABASE. Available from. http://www.covidibd.org.Garg M., Royce S.G., Tikellis C. Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? Gut. 2020; 69:841—851. doi: 10.1136/gutjnl-2019-318512.Garg M., Royce S.G., Tikellis C. Imbalance of the renin-angiotensin system may contribute to inflammation and fibrosis in IBD: a novel therapeutic target? Gut. 2020; 69:841—851. doi: 10.1136/gutjnl-2019-318512.Ning L., Shan G., Sun Z. Quantitative proteomic analysis reveals the deregulation of nicotinamide adenine dinucleotide metabolism and CD38 in inflammatory bowel disease. Biomed Res Int. 2019; 2019:3950628.Ning L., Shan G., Sun Z. Quantitative proteomic analysis reveals the deregulation of nicotinamide adenine dinucleotide metabolism and CD38 in inflammatory bowel disease. Biomed Res Int. 2019; 2019:3950628.Ibrahim I.M., Abdelmalek D.H., Elshahat M.E. COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect. 2020; 80:554—562. doi: 10.1016/j.jinf.2020.02.026.Ibrahim I.M., Abdelmalek D.H., Elshahat M.E. COVID-19 spike-host cell receptor GRP78 binding site prediction. J Infect. 2020; 80:554—562. doi: 10.1016/j.jinf.2020.02.026.Jablaoui A., Kriaa A., Mkaouar H., Akermi N., Soussou S., Wysocka M., et al. Fecal Serine Protease Profiling in Inflammatory Bowel Diseases. Front Cell Infect Microbiol. 2020 Feb 4;10:21. doi: 10.3389/fcimb.2020.00021.Jablaoui A., Kriaa A., Mkaouar H., Akermi N., Soussou S., Wysocka M., et al. Fecal Serine Protease Profiling in Inflammatory Bowel Diseases. Front Cell Infect Microbiol. 2020 Feb 4;10:21. doi: 10.3389/fcimb.2020.00021.IOIBD Update on COVID19 for Patients with Crohn's Disease and Ulcerative Colitis. 2020. Available from: https://www.ioibd.org/ioibd-update-on-covid19-for-patients-with-crohns-disease-and-ulcerative-colitis/IOIBD Update on COVID19 for Patients with Crohn's Disease and Ulcerative Colitis. 2020. Available from: https://www.ioibd.org/ioibd-update-on-covid19-for-patients-with-crohns-disease-and-ulcerative-colitis/Turner D., Huang Y., Martm-de-Carpi J., Aloi M., Focht G., Kang B., et al. COVID-19 and Paediatric Inflammatory Bowel Diseases; Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2020 doi: 10.1097/MPG.0000000000002729.Turner D., Huang Y., Martm-de-Carpi J., Aloi M., Focht G., Kang B., et al. COVID-19 and Paediatric Inflammatory Bowel Diseases; Global Experience and Provisional Guidance (March 2020) from the Paediatric IBD Porto group of ESPGHAN. J Pediatr Gastroenterol Nutr. 2020 doi: 10.1097/MPG.0000000000002729.

The authors declare that there are no conflicts of interest present.